Form 4 for CRVL CORVEL CORP
Accepted 2023-02-06 00:00:00 ET · period of report 2023-02-02 · accession 0001754499-23-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-02-06 | 2023-02-02 | CRVL | O'Brien Brandon | CFO | F - Tax | $189.02 | -725 | 2,826 | -20% | -$137.0K |
| DM | 2023-02-06 | 2023-02-02 | CRVL | O'Brien Brandon | CFO | M - OptEx | $58.65 | +1,233 | 2,882 | +75% | +$72.3K |
| DM | 2023-02-06 | 2023-02-02 | CRVL | O'Brien Brandon | CFO | M - OptEx | $189.02 | -1,233 | 0 | -100% | -$233.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-02 | F | D | 12 | $189.02 | 2,708 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-02 | F | D | 313 | $189.02 | 3,460 | D | — | — | |
| 3 | Common | Common Stock | 2023-02-02 | M | A | 1,000 | $59.32 | 3,773 | D | — | — | |
| 4 | Common | Common Stock | 2023-02-02 | F | D | 53 | $189.02 | 2,773 | D | — | — | |
| 5 | Common | Common Stock | 2023-02-02 | M | A | 46 | $49.40 | 2,720 | D | — | — | |
| 6 | Common | Common Stock | 2023-02-02 | F | D | 278 | $189.02 | 3,182 | D | — | — | |
| 7 | Common | Common Stock | 2023-02-02 | F | D | 13 | $189.02 | 2,695 | D | — | — | |
| 8 | Common | Common Stock | 2023-02-02 | M | A | 187 | $57.35 | 2,882 | D | — | — | |
| 9 | Common | Common Stock | 2023-02-02 | F | D | 56 | $189.02 | 2,826 | D | — | — | |
| 10 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-02-02 | M | D | 46 | $189.02 | 0 | D | $49.40 · — to 2023-05-03 | 46 Common Stock | (F2) Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter. |
| 11 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-02-02 | M | D | 1,000 | $189.02 | 1,000 | D | $59.32 · — to 2023-11-01 | 1,000 Common Stock | (F3) Option will vest based on achievement of certain performance criteria relating to earnings growth. |
| 12 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-02-02 | M | D | 187 | $189.02 | 0 | D | $57.35 · — to 2023-08-02 | 187 Common Stock | (F2) Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter. |